AHA Scientific Sessions 2025 Abstract
Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients With Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline
Trial in peopleInterventions
The paper
Saint Luke's Hospital; Azienda Ospedaliero-Universitaria Careggi
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4363872
